About Pathfinder Cell Therapy
Pathfinder Cell Therapy is developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. Pathfinder has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells (“PCs”) themselves being incorporated into the new tissue.
Pathfinder Cells have a unique set of properties:
- PCs can be found in a number of different organs including the kidney, liver, pancreas, lymph nodes, myometrium, bone marrow and blood
- PCs are “immune privileged” and are able to work across species or between immunologically different individuals
- PCs can be differentiated from other cell types through cell surface and other markers
- PCs can stimulate the regeneration of a number of organs independent of the tissue source of the PCs